Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
The Journal of Urology
|
May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology
|
July 14, 2021
Reply by Authors
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Harefuah
|
June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]
Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
European Urology Oncology
|
October 10, 2022
Neoadjuvant <sup>177</sup>Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial
Shay Golan, Michael Frumer, Yarden Zohar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis
Jonathan I Izawa, Paul Sweeney, Paul Perrotte, et al.
The Journal of Urology
|
July 4, 2014
A novel urine cytology stain for the detection and monitoring of bladder cancer
Noa Davis, Yoram Mor, Pavel Idelevich, et al.
Neoplasia (New York, N.Y.)
|
October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
Khalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production
Paul Sweeney, Takashi Karashima, Sun-Jin Kim, et al.
The Journal of Urology
|
September 6, 2019
Reply By Authors
David Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology
|
June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
David Margel, Avivit Peer, Yaara Ber, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
The Journal of Urology
|
May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology
|
July 14, 2021
Reply by Authors
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Harefuah
|
June 30, 2017
[THE MULTIDISCIPLINARY MUSCLE INVASIVE BLADDER CANCER CLINIC AT THE RABIN MEDICAL CENTER]
Sharon Noroheimer, Rachel Ozalvo, Amir Abramovich, et al.
European Urology Oncology
|
October 10, 2022
Neoadjuvant <sup>177</sup>Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial
Shay Golan, Michael Frumer, Yarden Zohar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis
Jonathan I Izawa, Paul Sweeney, Paul Perrotte, et al.
The Journal of Urology
|
July 4, 2014
A novel urine cytology stain for the detection and monitoring of bladder cancer
Noa Davis, Yoram Mor, Pavel Idelevich, et al.
Neoplasia (New York, N.Y.)
|
October 26, 2005
The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
Khalid A Mohamedali, Daniel Kedar, Paul Sweeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production
Paul Sweeney, Takashi Karashima, Sun-Jin Kim, et al.
The Journal of Urology
|
September 6, 2019
Reply By Authors
David Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology
|
June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
David Margel, Avivit Peer, Yaara Ber, et al.
Page
of 5